JAK Signaling May Be Behind Polymyalgia Rheumatica

MONDAY, July 10, 2023 -- Janus tyrosine kinase (JAK) signaling may be involved in the pathogenesis of polymyalgia rheumatica (PMR), and tofacitinib may be an effective treatment, according to a pilot study published online June 29 in PLOS...